CRISPR Therapeutics AG Quarterly Unrecognized Tax Benefits in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CRISPR Therapeutics AG quarterly Unrecognized Tax Benefits history and growth rate from Q4 2015 to Q4 2023.
  • CRISPR Therapeutics AG Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $44.1M, a 27.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $44.1M +$9.61M +27.8% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $34.5M +$13.1M +61.4% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $21.4M +$9.43M +78.8% Dec 31, 2021 10-K 2024-02-21
Q4 2020 $12M +$6.74M +129% Dec 31, 2020 10-K 2024-02-21
Q4 2019 $5.23M +$3.64M +228% Dec 31, 2019 10-K 2023-02-21
Q4 2018 $1.6M +$1.24M +351% Dec 31, 2018 10-K 2022-02-15
Q4 2017 $354K +$191K +117% Dec 31, 2017 10-K 2021-02-16
Q4 2016 $163K +$114K +233% Dec 31, 2016 10-K 2020-02-12
Q4 2015 $49K Dec 31, 2015 10-K 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.